SearchDictionaryMobileLogin

Julio S G Montaner Selected Research

HIV Infections (HIV Infection)

01/2005Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
10/2004Simplification of therapeutic drug monitoring for twice-daily regimens of lopinavir/ritonavir for HIV infection.
05/2003Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.
04/2002Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.
01/2002The T cell receptor V beta repertoire shows little change during treatment interruption-related viral rebound in chronic HIV infection.

Articles by Research Topic

Disease

5HIV Infections (HIV Infection)
01/2005 - 01/2002
3Hepatitis C
02/2008 - 01/2006
3Hypersensitivity (Allergy)
02/2008 - 06/2007
2Disease Progression
04/2008 - 02/2006
1Liver Diseases (Liver Disease)
02/2008
1Obesity
06/2006
1Infection
06/2006
1Exanthema (Rash)
05/2003
1Seizures (Seizure)
01/2003
1Acquired Immunodeficiency Syndrome (AIDS)
01/2003

Drug/Important Bio-Agent (IBA)

4Nevirapine (Viramune)FDA Link
02/2008 - 04/2002
1UniversalIBA
04/2008
1Carbon MonoxideIBA
02/2008
1tenofovirIBA
02/2008
1Lamivudine (3TC)FDA Link
02/2008
1HIV Reverse TranscriptaseIBA
06/2007
1abacavir (Ziagen)FDA Link
06/2007
1Anti-Bacterial Agents (Antibiotics)IBA
06/2006
1Reverse Transcriptase InhibitorsIBA
01/2005
1Ritonavir (Norvir)FDA Link
10/2004
1lopinavir (Kaletra)FDA Link
10/2004
1enfuvirtide (Fuzeon)FDA Link
05/2003
1Prednisone (Sone)FDA LinkGeneric
05/2003
1Street Drugs (Illicit Drugs)IBA
01/2003
1Heroin (Diamorphine)IBA
01/2003
1Stavudine (Zerit)FDA Link
04/2002
1Didanosine (Videx)FDA LinkGeneric
04/2002
1Hydroxyurea (Hydrea)FDA LinkGeneric
04/2002
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2002

Therapy/Procedure

2Highly Active Antiretroviral Therapy (HAART)
02/2006 - 01/2006